Register Login
Register to leave comments
  • News bot Aug. 28, 2026, 12:02 p.m.

    📋 BIOATLA, INC. (BCAB) - Clinical Trial Update

    Filing Date: 2026-08-28

    Accepted: 2026-08-28 08:01:39

    Event Type: Clinical Trial Update

    Event Details:

    BIOATLA, INC. (BCAB) Announces Clinical Trial Update BIOATLA, INC. (BCAB) provided an update on its clinical development programs. Clinical Development Highlights:
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Geopolitical Situation, Pandemic-Related Challenges, Regulatory Process
    • Collaboration: Common Stock

    🔬 Clinical Development Pipeline (BIOATLA, INC.):

    Product Type Development Stage Therapeutic Area Source
    Toripalimab Other Phase PHASE2 Ovarian Cancer ClinicalTrials.gov
    ENB003 Other Phase PHASE2 Ovarian Cancer ClinicalTrials.gov
    BA3021 Other Phase PHASE2 Ovarian Cancer ClinicalTrials.gov
    BA3011 Other Phase PHASE2 Ovarian Cancer ClinicalTrials.gov
    Durvalumab Other Phase PHASE2 Ovarian Cancer ClinicalTrials.gov
    Placebo Other Approved Metabolic Syndrome ClinicalTrials.gov
    Seaweed extract Other Approved Metabolic Syndrome ClinicalTrials.gov
    PD-1 inhibitor Other Phase PHASE1 Non Small Cell Lung Cancer ClinicalTrials.gov
    CAB-ROR2-ADC Other Phase PHASE1 Non Small Cell Lung Cancer ClinicalTrials.gov
    Pemetrexed (Alimta) Other Phase PHASE1 NSCLC ClinicalTrials.gov
    Pembrolizumab Other Phase PHASE1 NSCLC ClinicalTrials.gov
    Nivolumab Other Phase PHASE1 NSCLC ClinicalTrials.gov
    BA3071 Other Phase PHASE1 NSCLC ClinicalTrials.gov
    CAB-AXL-ADC Other Phase PHASE1 Undifferentiated Pleomorphic Sarcoma ClinicalTrials.gov
    BA3182 Other Phase PHASE1 Advanced Adenocarcinoma ClinicalTrials.gov
    Cetuximab Other Phase PHASE2 Head and Neck Cancer ClinicalTrials.gov
    Evalstotug (BA3071) Other Phase PHASE2 Head and Neck Cancer ClinicalTrials.gov
    Ozuriftamab Vedotin Other Phase PHASE2 Head and Neck Cancer ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: BIOATLA, INC.
    • Ticker Symbol: BCAB

Search

News categories